Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gishel New

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
International Journal of Cardiology|May 7, 2013
Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registryThathya V Ariyaratne, Zanfina Ademi, Stephen J Duffy, et al.
The American Journal of Cardiology|May 13, 2017
Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)Julian Yeoh, Matias B Yudi, Nick Andrianopoulos, et al.
The Medical Journal of Australia|October 4, 2006
Use of drug-eluting stents in Victorian public hospitalsBryan P Yan, Andrew E Ajani, Stephen J Duffy, et al.
Cardiovascular Therapeutics|January 8, 2014
Cardiovascular medication use following percutaneous coronary intervention: the Australian experienceJustin A Cole, Angela L Brennan, Andrew E Ajani, et al.
Current Medical Research and Opinion|December 25, 2019
The cost-effectiveness of guideline-driven use of drug-eluting stents: propensity-score matched analysis of a seven-year multicentre experienceThathya V Ariyaratne, Zanfina Ademi, Richard Ofori-Asenso, et al.
International Journal of Cardiology|June 12, 2010
Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromesAli H Al-Fiadh, Nick Andrianopoulos, Omar Farouque, et al.
Journal of the American College of Cardiology|May 22, 2002
Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis modelNicholas N Kipshidze, Han Soo Kim, Patrick Iversen, et al.
American Heart Journal|April 21, 2009
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stentsMichelle J Butler, David Eccleston, David J Clark, et al.
The Medical Journal of Australia|October 22, 2008
Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registryAndrew E Ajani, Christopher M Reid, Stephen J Duffy, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shockHan S Lim, Omar Farouque, Nick Andrianopoulos, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|May 7, 2013
Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registryThathya V Ariyaratne, Zanfina Ademi, Stephen J Duffy, et al.
The American Journal of Cardiology|May 13, 2017
Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)Julian Yeoh, Matias B Yudi, Nick Andrianopoulos, et al.
The Medical Journal of Australia|October 4, 2006
Use of drug-eluting stents in Victorian public hospitalsBryan P Yan, Andrew E Ajani, Stephen J Duffy, et al.
Cardiovascular Therapeutics|January 8, 2014
Cardiovascular medication use following percutaneous coronary intervention: the Australian experienceJustin A Cole, Angela L Brennan, Andrew E Ajani, et al.
Current Medical Research and Opinion|December 25, 2019
The cost-effectiveness of guideline-driven use of drug-eluting stents: propensity-score matched analysis of a seven-year multicentre experienceThathya V Ariyaratne, Zanfina Ademi, Richard Ofori-Asenso, et al.
International Journal of Cardiology|June 12, 2010
Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromesAli H Al-Fiadh, Nick Andrianopoulos, Omar Farouque, et al.
Journal of the American College of Cardiology|May 22, 2002
Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis modelNicholas N Kipshidze, Han Soo Kim, Patrick Iversen, et al.
American Heart Journal|April 21, 2009
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stentsMichelle J Butler, David Eccleston, David J Clark, et al.
The Medical Journal of Australia|October 22, 2008
Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registryAndrew E Ajani, Christopher M Reid, Stephen J Duffy, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shockHan S Lim, Omar Farouque, Nick Andrianopoulos, et al.
Pageof 4